1. Home
  2. INKT vs CLPS Comparison

INKT vs CLPS Comparison

Compare INKT & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • CLPS
  • Stock Information
  • Founded
  • INKT 2017
  • CLPS 2005
  • Country
  • INKT United States
  • CLPS Hong Kong
  • Employees
  • INKT N/A
  • CLPS N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • CLPS Computer Software: Prepackaged Software
  • Sector
  • INKT Health Care
  • CLPS Technology
  • Exchange
  • INKT Nasdaq
  • CLPS Nasdaq
  • Market Cap
  • INKT 36.7M
  • CLPS 35.1M
  • IPO Year
  • INKT 2021
  • CLPS 2018
  • Fundamental
  • Price
  • INKT $10.10
  • CLPS $1.27
  • Analyst Decision
  • INKT Strong Buy
  • CLPS
  • Analyst Count
  • INKT 2
  • CLPS 0
  • Target Price
  • INKT $6.50
  • CLPS N/A
  • AVG Volume (30 Days)
  • INKT 70.0K
  • CLPS 24.5K
  • Earning Date
  • INKT 03-20-2025
  • CLPS 03-04-2025
  • Dividend Yield
  • INKT N/A
  • CLPS 10.24%
  • EPS Growth
  • INKT N/A
  • CLPS N/A
  • EPS
  • INKT N/A
  • CLPS N/A
  • Revenue
  • INKT N/A
  • CLPS $142,812,726.00
  • Revenue This Year
  • INKT N/A
  • CLPS N/A
  • Revenue Next Year
  • INKT N/A
  • CLPS N/A
  • P/E Ratio
  • INKT N/A
  • CLPS N/A
  • Revenue Growth
  • INKT N/A
  • CLPS N/A
  • 52 Week Low
  • INKT $4.56
  • CLPS $0.68
  • 52 Week High
  • INKT $19.00
  • CLPS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • INKT 54.73
  • CLPS 50.44
  • Support Level
  • INKT $8.97
  • CLPS $1.19
  • Resistance Level
  • INKT $9.98
  • CLPS $1.36
  • Average True Range (ATR)
  • INKT 1.44
  • CLPS 0.09
  • MACD
  • INKT -0.07
  • CLPS -0.00
  • Stochastic Oscillator
  • INKT 42.97
  • CLPS 47.37

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

Share on Social Networks: